Stephanie LucasStephanie Lucas Facebook ad: “And Potential Side Effects”
Started on January 19, 2026.
Run by Stephanie Lucas on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 2609755352742689
- Platforms
- Facebook, Instagram, Audience Network, Messenger and Threads
- Relaunches
- 0
Ad text
Leqembi (Lecanemab) Explained: How It’s Used, Who It’s For
Where the ad sends people
learntraveltip.com
And Potential Side Effects
Leqembi, also known by its generic name lecanemab, is one of the first disease-modifying treatments approved for early Alzheimer’s disease. Unlike traditional medications that mainly address symptoms, Leqembi targets a biological hallmark of Alzheimer’s, aiming to slow cognitive decline rather t...
Learn more: learntraveltip.com(opens in a new tab)
